95 related articles for article (PubMed ID: 15933858)
1. Home blood glucose prediction: clinical feasibility and validation in islet cell transplantation candidates.
Albisser AM; Baidal D; Alejandro R; Ricordi C
Diabetologia; 2005 Jul; 48(7):1273-9. PubMed ID: 15933858
[TBL] [Abstract][Full Text] [Related]
2. Home blood glucose prediction: validation, safety, and efficacy testing in clinical diabetes.
Albisser AM; Sakkal S; Wright C
Diabetes Technol Ther; 2005 Jun; 7(3):487-96. PubMed ID: 15929680
[TBL] [Abstract][Full Text] [Related]
3. Insulin independence of unstable diabetic patient after single living donor islet transplantation.
Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Shapiro JA; Tanaka K
Transplant Proc; 2005 Oct; 37(8):3427-9. PubMed ID: 16298617
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.
Ryan EA; Shandro T; Green K; Paty BW; Senior PA; Bigam D; Shapiro AM; Vantyghem MC
Diabetes; 2004 Apr; 53(4):955-62. PubMed ID: 15047610
[TBL] [Abstract][Full Text] [Related]
5. Continuous glucose monitoring: quality of hypoglycaemia detection.
Zijlstra E; Heise T; Nosek L; Heinemann L; Heckermann S
Diabetes Obes Metab; 2013 Feb; 15(2):130-5. PubMed ID: 22974231
[TBL] [Abstract][Full Text] [Related]
6. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects.
Paty BW; Senior PA; Lakey JR; Shapiro AM; Ryan EA
Diabetes Technol Ther; 2006 Apr; 8(2):165-73. PubMed ID: 16734547
[TBL] [Abstract][Full Text] [Related]
7. A graphical user interface for diabetes management that integrates glucose prediction and decision support.
Albisser AM
Diabetes Technol Ther; 2005 Apr; 7(2):264-73. PubMed ID: 15857228
[TBL] [Abstract][Full Text] [Related]
8. The surveillance error grid.
Klonoff DC; Lias C; Vigersky R; Clarke W; Parkes JL; Sacks DB; Kirkman MS; Kovatchev B;
J Diabetes Sci Technol; 2014 Jul; 8(4):658-72. PubMed ID: 25562886
[TBL] [Abstract][Full Text] [Related]
9. Neural network-based real-time prediction of glucose in patients with insulin-dependent diabetes.
Pappada SM; Cameron BD; Rosman PM; Bourey RE; Papadimos TJ; Olorunto W; Borst MJ
Diabetes Technol Ther; 2011 Feb; 13(2):135-41. PubMed ID: 21284480
[TBL] [Abstract][Full Text] [Related]
10. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
11. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
[TBL] [Abstract][Full Text] [Related]
12. Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.
Kovatchev BP; Clarke WL; Breton M; Brayman K; McCall A
Diabetes Technol Ther; 2005 Dec; 7(6):849-62. PubMed ID: 16386091
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
de Galan BE; Schouwenberg BJ; Tack CJ; Smits P
Neth J Med; 2006 Sep; 64(8):269-79. PubMed ID: 16990690
[TBL] [Abstract][Full Text] [Related]
14. Multi-Hour Blood Glucose Prediction in Type 1 Diabetes: A Patient-Specific Approach Using Shallow Neural Network Models.
Kushner T; Breton MD; Sankaranarayanan S
Diabetes Technol Ther; 2020 Dec; 22(12):883-891. PubMed ID: 32324062
[No Abstract] [Full Text] [Related]
15. [Islet transplantation for treatment of type-1 diabetes mellitus].
Saudek F; Girman P; Kríz J; Berková Z; Zacharovová K; Koblas T; Pektorová L; Vávrová E; Mindlová M; Habart D; Peregrin J; Lipár K; Oliverius M; Dovolilová E; Cíhalová E; Bobek V
Cas Lek Cesk; 2011; 150(1):49-55. PubMed ID: 21404489
[TBL] [Abstract][Full Text] [Related]
16. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
UK Hypoglycaemia Study Group
Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography-based continuous noninvasive glucose monitoring in patients with diabetes.
Gabbay RA; Sivarajah S
Diabetes Technol Ther; 2008 Jun; 10(3):188-93. PubMed ID: 18473692
[TBL] [Abstract][Full Text] [Related]
18. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success.
Koh A; Senior P; Salam A; Kin T; Imes S; Dinyari P; Malcolm A; Toso C; Nilsson B; Korsgren O; Shapiro AM
Transplantation; 2010 Feb; 89(4):465-71. PubMed ID: 20177350
[TBL] [Abstract][Full Text] [Related]
19. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.
Ghofaili KA; Fung M; Ao Z; Meloche M; Shapiro RJ; Warnock GL; Elahi D; Meneilly GS; Thompson DM
Transplantation; 2007 Jan; 83(1):24-8. PubMed ID: 17220786
[TBL] [Abstract][Full Text] [Related]
20. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
Edelman SV; Callahan P; Deeb LC
Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
